Vanda Pharmaceuticals

Vanda Pharmaceuticals

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$3.81
Previous Close
$3.75
Day Range
$3.72-$3.90
52W Range
$3.64-$9.94
Market Cap
$234.6M
Shares Short
8M

Financials

See more
Revenue (12 Mos)
$229.2M
Revenue Growth (YoY)
24.1%
Gross Profit (12 Mos)
$214.5M
Diluted EPS
-$4.72

News

See more

Yahoo Finance • 7 days ago

Vanda targets full-year 2026 total revenues greater than $240M as BYSANTI launch nears Q4

Yahoo Finance • last month

Vanda posts late-stage trial win for HETLIOZ in DSWPD, setting up another label expansion

Yahoo Finance • last month

Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ®(tasimelteon) in Delayed Sleep-Wake Phase Disorder

Yahoo Finance • 6 months ago

Charcot-Marie-Tooth Disease Market Growth to Accelerate Significantly During the Forecast Period (2026-2036) Driven by the Launch of Emerging Disease-Modifying Therapies | DelveInsight

About

CEO
Dr. Mihael H. Polymeropoulos M.D.
CFO
Mr. Kevin Patrick Moran
Address
2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
533